Biological samples from subjects are the most valuable assets that travel across the clinical trial’s supply chain. Any gap in knowledge in the biological sample’s lifecycle can make the subject non-evaluable and jeopardize overall data integrity. This white paper details the traceable chain of custody requirements that a system must meet to maintain an immutable record of all the steps a biological sample takes throughout its journey.